Bioconjugate & ADC Formulation Development - Abzena

Bioconjugate Formulation Development

Tailored formulation development for bioconjugates including ADCs, AOCs, RDCs and more.

Download Info Sheet

Robust formulations tailored to your needs.

Customized for your bioconjugate or antibody drug conjugate (ADC) development phase, Abzena will align your drug to your preferred target product profile (TPP) with a comprehensive range of formulation development packages including stable liquid and lyophilized formulations.

Contact Us

We select your best lead candidate through screening of optimal buffer conditions and formulation options to inform successful drug substance manufacturing conditions and drug product forms that support long-term stability.

Our team is experienced in developing formulations for small and large therapeutic molecules such as peptides, proteins, monoclonal antibodies and antibody-drug conjugates (ADCs).

Our Capabilities

We have the latest analytical equipment and methods to evaluate the integrity of your drug under an array of conditions to inform optimal formulation constituents and forms.

Our capabilities include:

  • UHPLC systems
  • Biophysical stability assessment platforms and particle size assessment equipment such as Prometheus, UNcle and ZetaSizer Ultra
  • Mass spectrometry instruments (TOF MS, QTOF MS)
  • Microfluidic platform (LabChip)
Contact Us

Preclinical Analytical Development Support

Bioconjugate & ADC Formulation Development - Abzena

Abzena provides a robust suite of analytical method development services designed to support bioconjugate formulation development. These analytical methods inform critical decisions and de-risk subsequent development phases. Through stress testing, forced degradation studies, and excipient compatibility assays, we identify optimal formulation conditions to maintain stability, extend shelf life, and that are appropriate for the desired route of administration. Particle size analysis and charge variant profiling further confirm that the product remains within defined quality attributes.

We also produce toxicology-ready batches under controlled conditions to support pre-clinical studies, ensuring consistent product characterization and safety.

Analytical Method Development

Related Content

Process Development & Optimization

Our experts collaborate together to develop quality, commercially viable processes ensuring seamless scale up through to commercial launch.

Learn More

Linker Payload

Supporting candidate ranking and lead selection, we determine the optimal design of linker payload architecture and profiling.

Learn More

cGMP Bioconjugate & ADC Manufacturing

We are experienced in offering reliable, predictable clinical to commercial cGMP bioconjugates & ADC manufacturing.

Learn More
Let’s move medicine forward - Abzena

Let’s move medicine forward.

The treatments you’re developing right now can make a real difference for human health. We can work together to ensure your success, combining our deep scientific and technical know-how with your promising asset.

Contact Us